← Leaderboards
Anna Zolkiewska
Kansas State University
$3,339,579
Attributed
$3,339,579
Total exposure
8
Grants
5
Lead (contact PI)
Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants. They are the sole PI on all grants (the two match).
Funding over time
peak $444K · FY2005–23$500K$375K$250K$125K$0
'05
'06
'07
'08
'09
'10
'11
'12
'13
'14
'15
'16
'17
'18
'19
'20
'21
'22
'23
Funding mix
By agency
NIH$3,339,579 · 8
By mechanism
R01$2,091,879 · 2
R15$444,000 · 1
R21$433,945 · 1
R03$219,920 · 2
P20$149,835 · 2
Top collaborators
No co-investigators on record.
Others in their field
Top investigators on “Cells”
- Lawrence Corey · Fred Hutchinson Cancer Center$536,344,731
- Barton F Haynes · Duke University$457,457,619
- David Heimbrook · Leidos Biomedical Research, Inc.$454,789,509
- Glenda E Gray · Wits Health Consortium (Pty), Ltd$299,104,942
- Dennis R. Burton · Scripps Research Institute$278,781,854
- Mary M Horowitz · Medical College Of Wisconsin$237,383,608
Research focus
CellsIn VitroFamilyCell SurfaceMetalloproteasesMemberMalignant Breast NeoplasmMammary NeoplasmsMolecularCell Surface ProteinsBaseMalignant NeoplasmsDown-RegulationDisintegrinsMessenger RnaBreast Cancer CellTherapeutic TargetTumorOutcome ForecastCell LineInnovationPlayVariantBiology
Grant awards (16)
Mechanistic links between mutations in the CLPB gene and congenital neutropenia$191,406
R21 · FY2023 · AI · contact PI
Mechanistic links between mutations in the CLPB gene and congenital neutropenia$242,539
R21 · FY2022 · AI · contact PI
Role of ADAM12 in regulatory T cell accumulation within T11 claudin-low breast tumors$73,840
R03 · FY2020 · CA · contact PI
Role of ADAM12 in regulatory T cell accumulation within T11 claudin-low breast tumors$76,000
R03 · FY2019 · CA · contact PI
ADAM12 in Breast Tumor Initiating Cells$311,250
R01 · FY2016 · CA · contact PI
ADAM12 in Breast Tumor Initiating Cells$311,250
R01 · FY2015 · CA · contact PI
ADAM12 in Breast Tumor Initiating Cells$308,998
R01 · FY2014 · CA · contact PI
ADAM12 in Breast Tumor Initiating Cells$300,875
R01 · FY2013 · CA · contact PI
Structure-Function Analysis of Breast Cancer-Associated Mutations in ADAM12$444,000
R15 · FY2010 · CA · contact PI
Molecular Analysis of Metalloprotease Disintegrin ADAM12$207,652
R01 · FY2007 · GM · contact PI
Molecular Analysis of Metalloprotease Disintegrin ADAM12$213,854
R01 · FY2006 · GM · contact PI
Molecular Analysis of Metalloprotease Disintegrin ADAM12$219,000
R01 · FY2005 · GM
Molecular Analysis of Metalloprotease Disintegrin ADAM12$219,000
R01 · FY2004 · GM
COBRE: U KS: P6: STRUCTURE AND FUNCTION OF CELL ADHESION DOMAIN OF ADAM12$149,835
P20 · FY2004 · RR
Function of ADAM proteins and transmembrane signaling$0
P20 · FY2002 · RR
ADAM 12 DISINTEGRIN DOMAIN AND MYOBLAST FUSION$70,080
R03 · FY2000 · AR